Papers/PMID:39964702
Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.
Food & function2025The record
2 findings drawn from this paper, on 1 compound across 2 endpoints.
What it reported
How to read these marksWhat moved
2 findings
lutein — decreases LDL cholesterol
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Both intention-to-treat analysis and the per-protocol analysis showed significant reductions in plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and malonaldehyde levels in the lutein supplementation group compared with the placebo group.”
Quoted verbatim from Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.. - Study
- RCT
- Duration
- 7 months
- Dose
- 10 mg/day lutein
- Population
- adults with central obesity
lutein — decreases total cholesterol (TC)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×1“Both intention-to-treat analysis and the per-protocol analysis showed significant reductions in plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and malonaldehyde levels in the lutein supplementation group compared with the placebo group.”
Quoted verbatim from Effect of lutein supplementation on blood lipids and advanced glycation end products in adults with central obesity: a double-blind randomized controlled trial.. - Study
- RCT
- Duration
- 7 months
- Dose
- 10 mg/day lutein
- Population
- adults with central obesity